CAS 170277-31-3: Immunoglobulin G, anti-(human tumor necrosis factor), (human-mouse monoclonal cA2 heavy chain), disulfide with human-mouse monoclonal cA2 light chain, dimer

Description:Immunoglobulin G (IgG) is a type of antibody that plays a crucial role in the immune response by recognizing and neutralizing pathogens such as bacteria and viruses. The specific substance you mentioned is a monoclonal antibody designed to target human tumor necrosis factor (TNF), a cytokine involved in systemic inflammation and implicated in various autoimmune diseases. This particular IgG is a dimeric form, consisting of two heavy chains and two light chains, linked by disulfide bonds, which contribute to its structural stability and functionality. The human-mouse chimeric nature of this antibody indicates that it is derived from both human and mouse immunoglobulin sequences, enhancing its efficacy and reducing immunogenicity in therapeutic applications. Monoclonal antibodies like this one are often used in clinical settings to treat conditions such as rheumatoid arthritis and inflammatory bowel disease by inhibiting TNF activity, thereby reducing inflammation and associated symptoms. The CAS number 170277-31-3 uniquely identifies this specific compound in chemical databases.

Formula:Unspecified

Found 3 products.

Product data	Purity	Price range	Estimated delivery
Infliximab CRS REF: 41-Y0002047CAS: 170277-31-3	- - -	115.00 €	Mon 21 Apr 25
Infliximab (10 mg/ml) REF: 3D-FI139130CAS: 170277-31-3	Min. 95%	464.00 €~1,988.00 €	Tue 06 May 25
Infliximab REF: TM-T9921CAS: 170277-31-3	98% - 99.70%	97.00 €~1,208.00 €	Wed 11 Jun 25